Medical Marijuana Use Concerns


Studies have revealed how varying cannabinoid profiles in the same cannabis plant can cause effects that are specific to particular organs in the plant. The variability in this plant only means that there should be strict standardization before any Cannabis implementation in medicinal use is done.

The researchers led by Professor Bernstein demonstrated the variability found in the cannabis plant correlates with cannabinoid concentrations in inflorescence leaves, the flowers, and height. The composition difference found in the plant is known as the chemotype.

Ionome, which are the mineral nutrients partitioning the plant organs, was examined by the team. The team mainly focused on how these mineral nutrients partitioning the plants organs affect the metabolism of cannabinoid. Chemotype and ionome are both affected by the organ and locale of the plant.

Nevertheless, the physiological and chemical states of marijuana knowledge have been slow due to the legal restrictions hence leaving researchers with limited understanding of the medical cannabis potential. With the inspiration from metabolites and the variability of cannabinoids, researchers have embarked on studying the interrelations between a location in the body and chemical profiles.

Besides, Bernstein’s work and research are important in providing the cannabis physiological and chemical development knowledge that is available today. Despite some knowledge on the THC (which is the psychoactive cannabinoid) being discerned, the other effects still remain elusive.

Finally, it is surprising that the relationship between ionome and cannabis is still unknown, yet it is important in the understanding of marijuana metabolism. The missing information is important in the cannabis standardization efforts in the future for medical use. However, the issue is further worsened by the physiological and chemical variation knowledge gap. Bernstein’s work will play a future role in changing and providing more therapeutic options.